• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两剂流感疫苗接种方案能否更好地保护老年人?一项基于主体的建模研究。

Can a Two-Dose Influenza Vaccine Regimen Better Protect Older Adults? An Agent-Based Modeling Study.

作者信息

Williams Katherine V, Krauland Mary G, Harrison Lee H, Williams John V, Roberts Mark S, Zimmerman Richard K

机构信息

Department of Family Medicine, School of Medicine, University of Pittsburgh, Schenley Place, 5th Floor, Suite 520, Pittsburgh, PA 15260, USA.

Department of Health Policy and Management, School of Public Health, University of Pittsburgh, Pittsburgh, PA 15261, USA.

出版信息

Vaccines (Basel). 2022 Oct 26;10(11):1799. doi: 10.3390/vaccines10111799.

DOI:10.3390/vaccines10111799
PMID:36366307
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9697266/
Abstract

Older adults (age ≥ 65) are at high risk of influenza morbidity and mortality. This study evaluated the impact of a hypothetical two-dose influenza vaccine regimen per season to reduce symptomatic flu cases by providing preseason (first dose) and mid-season (second dose) protection to offset waning vaccine effectiveness (VE). The Framework for Reconstructing Epidemiological Dynamics (FRED), an agent-based modeling platform, was used to compare typical one-dose vaccination to a two-dose vaccination strategy. Primary models incorporated waning VE of 10% per month and varied influenza season timing (December through March) to estimate cases and hospitalizations in older adults. Additional scenarios modeled reductions in uptake and VE of the second dose, and overall waning. In seasons with later peaks, two vaccine doses had the largest potential to reduce cases (14.4% with February peak, 18.7% with March peak) and hospitalizations (13.1% with February peak, 16.8% with March peak). Reductions in cases and hospitalizations still resulted but decreased when 30% of individuals failed to receive a second dose, second dose VE was reduced, or overall waning was reduced to 7% per month. Agent-based modeling indicates that two influenza vaccine doses could decrease cases and hospitalizations in older individuals. The highest impact occurred in the more frequently observed late-peak seasons. The beneficial impact of the two-dose regimen persisted despite model scenarios of reduced uptake of the second dose, decreased VE of the second dose, or overall VE waning.

摘要

老年人(年龄≥65岁)患流感后发病和死亡风险较高。本研究评估了假设的每季度两剂流感疫苗接种方案的影响,通过提供季前(第一剂)和季中(第二剂)保护来抵消疫苗效力(VE)的下降,以减少有症状流感病例。基于主体的建模平台——重建流行病学动力学框架(FRED),被用于比较典型的单剂疫苗接种和两剂疫苗接种策略。主要模型纳入了每月10%的疫苗效力下降以及不同的流感季节时间(12月至3月),以估计老年人中的病例数和住院数。其他情景模拟了第二剂疫苗接种率和效力的降低以及总体效力下降情况。在流感高峰较晚的季节,两剂疫苗在减少病例数方面潜力最大(2月达到高峰时为14.4%,3月达到高峰时为18.7%),住院数方面也是如此(2月达到高峰时为13.1%,3月达到高峰时为16.8%)。当30%的个体未接种第二剂、第二剂疫苗效力降低或总体效力下降降至每月7%时,病例数和住院数仍会减少,但降幅减小。基于主体的建模表明,两剂流感疫苗可减少老年人中的病例数和住院数。在更常见的晚高峰季节,影响最大。尽管存在第二剂疫苗接种率降低、第二剂疫苗效力下降或总体疫苗效力下降等模型情景,但两剂接种方案的有益影响仍然存在。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79cd/9697266/691b6af57a80/vaccines-10-01799-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79cd/9697266/38aab4d60ff4/vaccines-10-01799-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79cd/9697266/691b6af57a80/vaccines-10-01799-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79cd/9697266/38aab4d60ff4/vaccines-10-01799-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79cd/9697266/691b6af57a80/vaccines-10-01799-g002.jpg

相似文献

1
Can a Two-Dose Influenza Vaccine Regimen Better Protect Older Adults? An Agent-Based Modeling Study.两剂流感疫苗接种方案能否更好地保护老年人?一项基于主体的建模研究。
Vaccines (Basel). 2022 Oct 26;10(11):1799. doi: 10.3390/vaccines10111799.
2
When to vaccinate for seasonal influenza? Check the peak forecast.何时接种季节性流感疫苗?查看高峰期预测。
Res Sq. 2024 Sep 9:rs.3.rs-4893237. doi: 10.21203/rs.3.rs-4893237/v1.
3
Waning of Influenza Vaccine Protection: Exploring the Trade-offs of Changes in Vaccination Timing Among Older Adults.流感疫苗保护效果减弱:探索老年人接种时间变化的权衡取舍。
Clin Infect Dis. 2020 Apr 10;70(8):1550-1559. doi: 10.1093/cid/ciz452.
4
Compressed Influenza Vaccination in U.S. Older Adults: A Decision Analysis.美国老年人的流感疫苗接种:决策分析。
Am J Prev Med. 2019 Apr;56(4):e135-e141. doi: 10.1016/j.amepre.2018.11.015. Epub 2019 Feb 14.
5
Within-season influenza vaccine waning suggests potential net benefits to delayed vaccination in older adults in the United States.季节性流感疫苗效力随时间推移而减弱,这表明在美国,老年人推迟接种疫苗可能具有潜在的净收益。
Vaccine. 2018 Sep 18;36(39):5910-5915. doi: 10.1016/j.vaccine.2018.08.007. Epub 2018 Aug 23.
6
Projecting influenza vaccine effectiveness: A simulation study.预测流感疫苗效力:一项模拟研究。
PLoS One. 2020 Nov 3;15(11):e0241549. doi: 10.1371/journal.pone.0241549. eCollection 2020.
7
Modelling of optimal timing for influenza vaccination as a function of intraseasonal waning of immunity and vaccine coverage.基于免疫的季节性衰减和疫苗覆盖率,对流感疫苗接种最佳时机的建模。
Vaccine. 2019 Oct 16;37(44):6768-6775. doi: 10.1016/j.vaccine.2019.08.069. Epub 2019 Sep 11.
8
Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015-2016 Season in Canada.超越抗原匹配:2015-2016 年加拿大流感季节疫苗效力的可能宿主和免疫流行病学影响因素。
J Infect Dis. 2017 Dec 19;216(12):1487-1500. doi: 10.1093/infdis/jix526.
9
Intraseason waning of influenza vaccine protection: Evidence from the US Influenza Vaccine Effectiveness Network, 2011-12 through 2014-15.流感疫苗保护作用的季节性减弱:来自美国流感疫苗有效性网络的证据,2011-12 至 2014-15 年。
Clin Infect Dis. 2017 Mar 1;64(5):544-550. doi: 10.1093/cid/ciw816. Epub 2016 Dec 29.
10
The Impact of Prior Season Vaccination on Subsequent Influenza Vaccine Effectiveness to Prevent Influenza-related Hospitalizations Over 4 Influenza Seasons in Canada.在加拿大的 4 个流感季中,既往季节接种对后续流感疫苗预防与流感相关住院的效果的影响。
Clin Infect Dis. 2019 Aug 30;69(6):970-979. doi: 10.1093/cid/ciy1009.

引用本文的文献

1
Estimated Burden of Influenza and Direct and Indirect Benefits of Influenza Vaccination.流感的估计负担以及流感疫苗接种的直接和间接益处
JAMA Netw Open. 2025 Jul 1;8(7):e2521324. doi: 10.1001/jamanetworkopen.2025.21324.
2
Bolstering influenza protection for older adults.加强老年人的流感防护。
Lancet Infect Dis. 2024 Oct;24(10):1064-1066. doi: 10.1016/S1473-3099(24)00403-1. Epub 2024 Jul 11.
3
Modeling the Impact of COVID-19 Mitigation Strategies in Pennsylvania, USA.美国宾夕法尼亚州新冠疫情缓解策略的影响建模

本文引用的文献

1
Impact of Low Rates of Influenza on Next-Season Influenza Infections.流感低感染率对下一季流感感染的影响。
Am J Prev Med. 2022 Apr;62(4):503-510. doi: 10.1016/j.amepre.2021.11.007. Epub 2022 Feb 24.
2
Waning Vaccine Effectiveness Against Influenza-Associated Hospitalizations Among Adults, 2015-2016 to 2018-2019, United States Hospitalized Adult Influenza Vaccine Effectiveness Network.2015-2016 年至 2018-2019 年美国住院成人流感疫苗有效性网络:成人因流感相关住院的疫苗有效性逐渐降低。
Clin Infect Dis. 2021 Aug 16;73(4):726-729. doi: 10.1093/cid/ciab045.
3
Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period.
MDM Policy Pract. 2024 Jun 20;9(1):23814683241260744. doi: 10.1177/23814683241260744. eCollection 2024 Jan-Jun.
4
The Impact of the COVID-19 Pandemic on Influenza Vaccination Attitudes and Actions in Spain's Adult Population.新冠疫情对西班牙成年人口流感疫苗接种态度和行为的影响。
Vaccines (Basel). 2023 Sep 23;11(10):1514. doi: 10.3390/vaccines11101514.
预测 SARS-CoV-2 的传播动力学,直至大流行后期。
Science. 2020 May 22;368(6493):860-868. doi: 10.1126/science.abb5793. Epub 2020 Apr 14.
4
Age-Related Differences in Hospitalization Rates, Clinical Presentation, and Outcomes Among Older Adults Hospitalized With Influenza-U.S. Influenza Hospitalization Surveillance Network (FluSurv-NET).美国流感住院监测网络(FluSurv-NET)中因流感住院的老年人在住院率、临床表现和预后方面的年龄差异
Open Forum Infect Dis. 2019 Jul 1;6(7). doi: 10.1093/ofid/ofz225.
5
Waning of Influenza Vaccine Protection: Exploring the Trade-offs of Changes in Vaccination Timing Among Older Adults.流感疫苗保护效果减弱:探索老年人接种时间变化的权衡取舍。
Clin Infect Dis. 2020 Apr 10;70(8):1550-1559. doi: 10.1093/cid/ciz452.
6
Compressed Influenza Vaccination in U.S. Older Adults: A Decision Analysis.美国老年人的流感疫苗接种:决策分析。
Am J Prev Med. 2019 Apr;56(4):e135-e141. doi: 10.1016/j.amepre.2018.11.015. Epub 2019 Feb 14.
7
Immunizing the Immune: Can We Overcome Influenza's Most Formidable Challenge?免疫免疫系统:我们能否战胜流感最严峻的挑战?
Vaccines (Basel). 2018 Sep 22;6(4):68. doi: 10.3390/vaccines6040068.
8
Seasonality in risk of pandemic influenza emergence.大流行性流感出现风险的季节性。
PLoS Comput Biol. 2017 Oct 19;13(10):e1005749. doi: 10.1371/journal.pcbi.1005749. eCollection 2017 Oct.
9
Repeated annual influenza vaccination and vaccine effectiveness: review of evidence.重复年度流感疫苗接种与疫苗效果:证据综述
Expert Rev Vaccines. 2017 Jul;16(7):1-14. doi: 10.1080/14760584.2017.1334554. Epub 2017 Jun 9.
10
Intraseason waning of influenza vaccine protection: Evidence from the US Influenza Vaccine Effectiveness Network, 2011-12 through 2014-15.流感疫苗保护作用的季节性减弱:来自美国流感疫苗有效性网络的证据,2011-12 至 2014-15 年。
Clin Infect Dis. 2017 Mar 1;64(5):544-550. doi: 10.1093/cid/ciw816. Epub 2016 Dec 29.